Regeneron Pharmaceuticals
REGN
#317
Rank
$75.65 B
Marketcap
$734.81
Share price
-3.09%
Change (1 day)
22.48%
Change (1 year)

Number of shares outstanding for Regeneron Pharmaceuticals (REGN)

Number of shares outstanding as of October 2026 : 102,800,000

According to Regeneron Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 102,800,000. At the end of 2026 the company had 102,800,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Regeneron Pharmaceuticals from 1996 to 2026

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20260.10 B-0.1%
20250.10 B-4.37%
20240.10 B0.94%
20230.10 B-0.37%
20220.10 B0.75%
20210.10 B0.76%
20200.10 B-3.48%
20190.10 B0.92%
20180.10 B1.1%
20170.10 B1.82%
20160.10 B1.3%
20150.10 B2.26%
20140.10 B2.63%
201398.86 M3.31%
201295.69 M5.1%
201191.04 M4.17%
201087.4 M9.44%
200979.86 M1.18%
200878.93 M19.48%
200766.06 M15.89%
200657.01 M1.85%
200555.97 M0.92%
200455.46 M5.27%
200352.69 M19.89%
200243.95 M1.43%
200143.32 M19.91%
200036.13 M17.99%
199930.62 M-12.5%
199835 M10.53%
199731.66 M24.53%
199625.42 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Johnson & Johnson
JNJ
2,408,228,000 2,242.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
1,905,000,000 1,753.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
540,000,000 425.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
2,393,200,000 2,228.02%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
147,700,000 43.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
133,606,000 29.97%๐Ÿ‡บ๐Ÿ‡ธ USA